Subject(s)
Camphor/metabolism , Dental Pulp Cavity/metabolism , Phenols/metabolism , Root Canal Therapy , Animals , Autoradiography , Diffusion , DogsABSTRACT
The effect of possible neutralizing agents on aqueous parachlorophenol were studied. Results indicated that saline, EDTAC, dentin, saliva, prolonged light exposure, and thermal extremes do not appreciably affect the antibacterial properties of aqueous parachlorophenol. The presence of blood and necrotic tissue demonstrated a marked inhibitory effect.
Subject(s)
Anti-Infective Agents, Local/pharmacology , Chlorides/pharmacology , Phenols/pharmacology , Blood , Dentin/drug effects , Drug Storage , Edetic Acid/pharmacology , Enterococcus faecalis/drug effects , Light , Necrosis/metabolism , Neutralization Tests , Saliva , Sodium Chloride/pharmacology , TemperatureSubject(s)
Dental Pulp Cavity/microbiology , Dentin/microbiology , Root Canal Therapy , Adolescent , Adult , Aged , Anti-Infective Agents, Local/pharmacology , Bacteria/drug effects , Bacteria/isolation & purification , Child , Humans , Middle Aged , Sodium Hypochlorite/pharmacology , Therapeutic IrrigationABSTRACT
The ability of coxsackievirus B-1 to pass the barriers of the circulatory system into whole saliva has been shown previously. In this investigation, the major salivary glands and the oral mucosa were studied, and their role as participants in the excretion of coxsackievirus B-1 during viremia was evaluated. The effect of the salivary-gland stimulant pilocarpine nitrate on both the salivary flow rate and the recovery of virus during viremia was determined. A comparison was made between the amount of virus recovered from whole saliva during viremia in animals deficient in one or both of the major salivary-gland pairs and animals with a complete complement of salivary glands. The salivary glands in other animals were cannulated, and pure glandular secretions were collected during viremia and assayed for the presence of virus The amount of virus passing from the capillaries of the oral mucosa to the surface was also determined to evaluate this route as a possible site for the excretion of virus into saliva during viremia. The major salivary glands did not excrete appreciable quantities of virus during viremia. The submaxillary-gland secretions did not contain virus, and the parotid-gland secretions showed virus only at extremely high blood virus levels. Either removal of the major salivary glands or decreased salivary flow rates increased the concentration of virus in whole saliva. This observation suggested that the production of saliva by the major salivary glands tends to dilute the virus in the oral cavity. A 0.88-cm(2) sample of the oral mucosa excreted significantly large amounts of virus during viremia and suggested that the passage of virus through the oral mucosa was the major route for the excretion of virus into saliva during viremia.
Subject(s)
Enterovirus/isolation & purification , Mouth Mucosa/physiology , Saliva/microbiology , Salivary Glands/physiology , Animals , Female , Permeability , Pilocarpine/pharmacology , Rabbits , Salivation/drug effectsABSTRACT
Coxsackie B-1 virus was injected into the ear vein of albino doe rabbits. Saliva and blood samples were taken before the injection of virus and at specific times thereafter. Virus was recovered in the whole saliva when the blood titer was approximately 10(4) TCID(50) per 0.1 ml or greater. The virus could be detected in the saliva as early as 2 min after the initiation of the viremia. The recovered virus was shown to be the same as the injected virus by serological identification of the recovered virus with neutralizing antibody for Coxsackie B-1 virus. These results suggest that virus may be transmitted to other animals in the saliva of animals who are in the viremic phase of infection without infection of the oropharyngeal tissues.
